term,pvalue,odds_ratio,log_pval
4-1BB-dependent immune response,0.017953197478093284,10.667008985879331,1.745858192020201
ACE inhibitor pathway,0.16337672711675139,5.932609937178755,0.7868098082970303
AKAP95 role in mitosis and chromosome dynamics,0.14662282396907042,6.724271844660194,0.8337984201977292
AKT phosphorylation of cytosolic targets,0.13812108773659357,7.204923717059638,0.859740010136222
AKT phosphorylation of nuclear targets,0.09433137905416296,11.210355987055015,1.0253438164545743
AKT signaling pathway,7.010541172588568e-05,21.544205340938554,4.154248455756973
ALK in cardiac myocytes,0.31392163042915083,2.723169771713461,0.5031787586791449
ALK1 pathway,0.028873961790521197,8.104585365853659,1.539493622571793
AMPK signaling,0.004809913647889527,6.283592269799167,2.3178627204207034
AP-1 transcription factor network,1.9971249841171093e-13,23.956185567010312,12.699594755252544
APC/C-mediated degradation of cell cycle proteins,0.5612472844942591,1.2260833530665405,0.2508457472483297
ATF2 transcription factor network,1.2833506924569488e-07,16.034789331271742,6.89165465072757
ATM pathway,0.00011884325726556203,11.672479747974798,3.925025453527128
ATM-dependent DNA damage response,9.061754705098918e-09,14.407899311591681,8.042787698023508
Abl role in Robo-Slit signaling,0.09433137905416296,11.210355987055015,1.0253438164545743
Acetylation and deacetylation of RelA in the nucleus,0.1550410986277819,6.303701456310679,0.8095531628533404
Actin cytoskeleton regulation,8.584939222227662e-16,11.942940013183916,15.06626277511513
Actions of nitric oxide in the heart,0.00010757149314299964,11.944508404328804,3.9683028031210195
Activated NOTCH1 signaling in the nucleus,0.27183590172757066,3.2511744440964607,0.5656931859681069
Activation of BH3-only proteins,0.16337672711675139,5.932609937178755,0.7868098082970303
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,0.14662282396907042,6.724271844660194,0.8337984201977292
Activation of NF-kappaB in B cells,0.004809913647889527,6.283592269799167,2.3178627204207034
Activation of NMDA receptor upon glutamate binding and postsynaptic events,0.0005206080046842264,12.03071573456969,3.2834891586173653
Activation of PKC through G-protein coupled receptors,0.07620181512199029,14.414701803051319,1.1180346836725295
Activation of TRKA receptors,0.001965540187726133,40.5619512195122,2.7065180721037385
Activation of calcium-permeable kainate receptor,0.005015798046164786,22.530081300813006,2.299659958062889
Activation of kainate receptors upon glutamate binding,0.03728631824585162,6.985365853658537,1.4284504979594466
Activation of the AP-1 family of transcription factors,2.8667980105800312e-06,58.51090781140042,5.54260290558188
Acute myeloid leukemia,5.175976753191572e-09,19.243042671614102,8.286007682877086
Adaptive immune system,3.7051659296544707e-08,4.325556506849315,7.431192338097689
Adherens junction actin cytoskeletal organization,0.25724407997113713,3.4757281553398056,0.5896546109890537
Adherens junction cell adhesion,4.2039218970221166e-13,22.40630196208846,12.37634536115174
Adhesion and diapedesis of granulocytes,0.14662282396907042,6.724271844660194,0.8337984201977292
Adhesion and diapedesis of lymphocytes,0.00933076950290206,15.594746716697937,2.0300825387740216
Adipocytokine signaling pathway,0.004565704281532014,6.382081280788177,2.340492220979356
Adipogenesis,0.002153752980551765,4.819263059701493,2.6668041085288072
Adrenergic pathway,9.445739080102595e-06,7.281183932346724,5.0247640551214525
Adrenoceptors,0.09433137905416296,11.210355987055015,1.0253438164545743
Advanced glycosylation endproduct receptor signaling,0.008139138839488623,16.89512195121951,2.0894215431504537
Agrin in postsynaptic differentiation,7.414345350991916e-06,14.748400852878465,5.129927188938095
Aldosterone-regulated sodium reabsorption,3.8375133197434694e-06,16.74546187979024,5.415950104106014
Allograft rejection,0.31392163042915083,2.723169771713461,0.5031787586791449
Alpha-4 beta-7 integrin signaling,0.00010764004244948699,43.668067226890756,3.9680261396376184
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling,3.677932616553683e-07,18.158875,6.434396231739317
Alpha-6 beta-4 integrin signaling pathway,1.437736459261536e-05,19.03740374037404,4.842320713937636
Alpha-9 beta-1 integrin pathway,0.2271817603048409,4.032621359223302,0.6436265396729137
Alpha-M beta-2 integrin signaling,0.0007655365356055408,10.762250453720506,3.1160340775545667
Alpha-V beta-3 integrin/OPN pathway,6.682349342339712e-10,34.78894472361809,9.175070823896242
Alpha-synuclein signaling,7.567924602543133e-07,22.958540630182423,6.121023203358718
Alternative NF-kappaB pathway,0.06700205450091128,16.817961165048544,1.1739118802136672
Alzheimer's disease,0.006884690104629858,3.754823443756825,2.162115603537512
Amine ligand-binding G-protein coupled receptors,0.06709649013999916,4.938013087447948,1.1733001974569217
Amino acid and oligopeptide SLC transporters,0.39096768421699774,2.0550822270655833,0.40785913811881375
Amoebiasis,0.0006421756334577817,6.177014925373134,3.192346177211732
Amyotrophic lateral sclerosis (ALS),0.09922531085067118,3.8913696060037526,1.0033775318713434
Androgen receptor proteolysis and transcription regulation,0.1247430874067818,3.371219512195122,0.9039835113099347
Androgen receptor regulation of biosynthesis and transcription,0.016196654053573338,5.980968858131488,1.7905746938619844
"Androgen receptor signaling, proteolysis, and transcription regulation",2.373886369433305e-07,11.768749999999999,6.624540073211742
Angiogenesis,2.4525237647616597e-09,42.77411764705882,8.610386775648381
Angiopoietin receptor Tie2-mediated signaling,3.601833455134422e-17,41.824697754749565,16.443476372357214
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling,4.56655856961786e-09,26.081658291457288,8.34041096782036
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin,3.5043592906408975e-06,12.5125,5.455391373410511
"Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins",0.10974482009807505,2.0257583527277028,0.9596159690895955
Antigen processing: cross presentation,0.5479604177412752,1.2728278235221826,0.26125081191236166
Antigen-activated B-cell receptor generation of second messengers,4.377357049228269e-21,15.914631972910353,20.358788027710546
Antiviral mechanism by interferon-stimulated genes,0.5056492391668718,1.4371012482662968,0.29615064189091894
Apoptosis,3.760486798395244e-11,8.706031746031748,10.424755931622231
Apoptosis intrinsic pathway,0.26457600536198,3.3597087378640773,0.5774495449232956
Apoptosis modulation and signaling,1.5322198604501595e-05,9.799527027027027,4.814678912686846
Apoptosis modulation by HSP70,0.1798032676389488,5.30761369443025,0.7452024199183122
Apoptosis regulation,0.18302428109417712,2.6247703515996204,0.7374912903477465
Apoptotic cleavage of cellular proteins,0.0006905503447859054,20.370588235294118,3.1608046535579435
Apoptotic execution  phase,0.0154064471362638,6.100882352941176,1.8122975019055534
Apoptotic signaling in response to DNA damage,0.18789577114699169,5.041990291262136,0.7260829941846972
Aquaporin-mediated transport,0.09008537069174385,4.1302140368342455,1.0453457300387008
Arf6 integrin-mediated signaling pathway,0.013169588727630412,6.491239048811013,1.8804277873851862
Arf6 signal transduction regulation,1.4157392117799004e-12,40.54470909800859,11.849016739100911
Arf6 vesicle-mediated transport,0.00048084627712253786,23.50678733031674,3.3179937420622956
Arginine and proline metabolism,0.4204699387447968,1.8643473570658036,0.3762650483891087
Arrhythmogenic right ventricular cardiomyopathy (ARVC),0.0009288159627920334,7.224236508157858,3.0320703293451463
Attenuation of GPCR signaling,0.11210683500664335,9.171226831421007,0.9503679082330622
Atypical NF-kappaB pathway,0.013335414315298676,12.66890243902439,1.8749934867567992
Aurora B signaling,0.32740511109940934,2.5832710978342046,0.4849145451288914
Autoimmune thyroid disease,0.4088436802553104,1.936239731142644,0.3884427110131555
Axon guidance,2.153218964270407e-16,9.812486187845305,15.66691180383233
Axonal growth stimulation,0.05771112388474198,20.182524271844663,1.2387404680204133
Axonogenesis regulation by p75 neurotrophin receptor,0.09433137905416296,11.210355987055015,1.0253438164545743
B cell survival pathway,0.011930429429686152,13.514146341463414,1.923343923841263
B lymphocyte cell surface molecules,0.11210683500664335,9.171226831421007,0.9503679082330622
BAD activation and translocation to mitochondria,0.07620181512199029,14.414701803051319,1.1180346836725295
BAD phosphorylation mediated by IGF1R signaling,3.2355433309764397e-06,27.06357477853048,5.490052779653255
BAD phosphorylation regulation,8.114394533501107e-09,34.62,8.090743880097689
BARD1 signaling events,0.25724407997113713,3.4757281553398056,0.5896546109890537
BDNF signaling pathway,1.2018692228672447e-05,5.056738461538462,4.9201427859747255
BMAL1-CLOCK/NPAS2 activates circadian expression,0.3206966625110689,2.6513796627491053,0.4939055597490413
BMP receptor signaling,0.06709649013999916,4.938013087447948,1.1733001974569217
BTG family proteins and cell cycle regulation,0.0059800607864769675,20.27609756097561,2.223294401446815
Bacterial invasion of epithelial cells,0.0007261094945246084,7.657011969853701,3.138997884420759
Basal cell carcinoma,0.017844319993422352,5.754716981132075,1.7484999973710444
Base excision repair,0.3001691788307718,2.8790568654646322,0.5226339028685755
Beta-1 integrin cell surface interactions,0.02851800962169252,4.763097426470589,1.5448807887949387
Beta-3 integrin cell surface interactions,7.044024574265602e-05,13.172124904798173,4.152179137592704
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling,0.013335414315298676,12.66890243902439,1.8749934867567992
Beta-catenin phosphorylation cascade,0.16337672711675139,5.932609937178755,0.7868098082970303
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs),0.08531129607996224,12.612257281553399,1.0689934600354087
Bioactive peptide-induced signaling pathway,3.329233606382538e-06,17.21144278606965,5.4776557301051625
Bladder cancer,3.114168571012009e-10,27.75267379679144,9.50665788262247
Bone remodeling,3.164979791586005e-05,27.29458128078818,4.499629058610513
Bystander B cell activation,0.08531129607996224,12.612257281553399,1.0689934600354087
C-Myb transcription factor network,2.1378824617404835e-06,10.676459219172786,5.670016175469956
C-Myc pathway,0.026906925653485875,8.442682926829269,1.5701359212626682
CARM1 and regulation of the estrogen receptor,0.2348089833246225,3.877333831217326,0.6292852918635983
CARM1 transcriptional regulation by protein methylation,0.13812108773659357,7.204923717059638,0.859740010136222
CBL signaling regulation,0.0008140941973240391,19.096507352941178,3.0893253407973162
CBL-mediated ligand-induced downregulation of EGF receptors,8.496182824273008e-06,40.95172413793103,5.070776150839037
CCR3 signaling in eosinophils,0.001445330146353347,15.274264705882354,2.840032938815726
CD28 co-stimulation,0.0037928215035731975,10.529411764705882,2.421037595429896
CD28-dependent PI3K/Akt signaling,0.01962192192519719,10.133170731707319,1.7072584566589855
CD28-dependent Vav1 pathway,0.0059800607864769675,20.27609756097561,2.223294401446815
CD40/CD40L signaling,0.0037928215035731975,10.529411764705882,2.421037595429896
CD40L signaling pathway,0.011930429429686152,13.514146341463414,1.923343923841263
CD8/T cell receptor downstream pathway,2.5086036903518125e-08,15.706818181818182,7.600567943184394
CDC42 activity regulation,0.26457600536198,3.3597087378640773,0.5774495449232956
CDC42 signaling events,7.169244610133395e-05,9.519173363949484,4.144526601505604
CDK regulation of DNA replication,0.1716305169121396,5.602750809061488,0.7654054895163487
CDO in myogenesis,0.25724407997113713,3.4757281553398056,0.5896546109890537
CREB phosphorylation,0.07620181512199029,14.414701803051319,1.1180346836725295
CREB transcription factor and its extracellular signals,0.001639880255060271,14.546218487394958,2.785187863211579
CRMPs in Sema3A signaling,0.011930429429686152,13.514146341463414,1.923343923841263
CTCF pathway,0.0025785349241538085,12.216470588235293,2.5886269820526633
CTL mediated immune response against target cells,0.12953506652101412,7.759522031366692,0.8876126475283884
CTLA4 inhibitory signaling,0.20384316548076056,4.5831862312444835,0.6907038451328491
CXCR4 signaling pathway,1.4312415316169288e-10,13.330541237113403,9.844287069946024
Cadmium-induced DNA biosynthesis and proliferation in macrophages,1.4349004073909805e-08,51.694029850746276,7.8431782411052655
Calcineurin in effects in keratinocyte differentiation,0.0009508300728066499,17.972318339100347,3.021897090882179
Calcineurin-dependent NFAT signaling role in lymphocytes,3.74555077182728e-09,20.06382978723404,8.426484311588572
Calcium regulation in the cardiac cell,2.4590866195672746e-06,7.488397389412617,5.609226173279362
Calcium signaling by HBx of hepatitis B virus,1.521027807606976e-05,34.1231527093596,4.8178628460522805
Calcium signaling pathway,1.7098951190646368e-06,6.890032798833819,5.767030527390535
Calcium/calmodulin-dependent protein kinase activation,0.09433137905416296,11.210355987055015,1.0253438164545743
Carbohydrate metabolism,0.00909935632509907,3.1429694323144104,2.040989327936561
Caspase cascade in apoptosis,0.02140978106583396,5.34984520123839,1.6693877737324818
Cell adhesion molecules (CAMs),5.609683133379199e-05,6.5939219909069156,4.251061669458889
Cell cycle,0.005566882487494916,2.5780854102363295,2.2543879462107843
Cell cycle checkpoints,0.6903145586964299,0.8578541199900424,0.16095296726814878
Cell cycle negative regulation by p75 neurotrophin receptor,0.06700205450091128,16.817961165048544,1.1739118802136672
Cell cycle progression regulation by PLK3,0.1798032676389488,5.30761369443025,0.7452024199183122
Cell cycle: G1/S checkpoint,0.002855343104681965,11.746040723981901,2.5443416984454075
Cell death signaling by NRIF in the nucleus,0.1550410986277819,6.303701456310679,0.8095531628533404
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model,7.044024574265602e-05,13.172124904798173,4.152179137592704
Cell differentiation pathway,0.017953197478093284,10.667008985879331,1.745858192020201
Cell junction organization,0.20445268292474886,2.4343226564795772,0.6894071860547725
Cell surface interactions at the vascular wall,1.6314101937699795e-10,15.35495829471733,9.787436828357029
Cell to cell adhesion signaling,0.013335414315298676,12.66890243902439,1.8749934867567992
Cell-cell communication,6.643231566692135e-07,8.744923857868018,6.177620608858498
Cell-extracellular matrix interactions,0.1550410986277819,6.303701456310679,0.8095531628533404
Cells and molecules involved in local acute inflammatory response,0.013335414315298676,12.66890243902439,1.8749934867567992
Ceramide signaling pathway,2.9298876694257248e-08,19.862167982770995,7.533149029981636
ChREBP regulation by carbohydrates and cAMP,0.19590881158612478,4.801664355062414,0.707946029869643
Chagas disease,3.5798129044e-11,15.078047960555805,10.446139670761148
Chemokine signaling pathway,5.470613914162533e-08,7.8049973789970295,7.261963934256602
Chondroitin sulfate biosynthesis,0.18789577114699169,5.041990291262136,0.7260829941846972
Chondroitin sulfate/dermatan sulfate degradation,0.12953506652101412,7.759522031366692,0.8876126475283884
Chondroitin sulfate/dermatan sulfate metabolism,0.0013733603733217551,9.085057471264367,2.8622154878111723
Chronic myeloid leukemia,6.718161959056762e-07,12.62494289629968,6.172749530551395
Circadian rhythm,0.12803561951661965,3.3157936825269894,0.8926691927933187
Ck1/Cdk5 regulation by type 1 glutamate receptors,0.0020762790538787854,13.28005115089514,2.682714277309507
Class A GPCRs (rhodopsin-like),0.10709632439738512,2.042228319217464,0.9702254341291698
Collagen binding in corneal epithelia mediated by Erk and PI-3 Kinase,3.2355433309764397e-06,27.06357477853048,5.490052779653255
Colorectal cancer,5.649639521240331e-10,19.863997701369602,9.247979261725796
Control of gene expression by vitamin D receptor,0.24236129059834613,3.733549083063646,0.615536743507379
Corticosteroids and cardioprotection,3.164979791586005e-05,27.29458128078818,4.499629058610513
Corticotropin releasing hormone pathway,0.0020762790538787854,13.28005115089514,2.682714277309507
Costimulation by the CD28 family,0.005874330555353722,5.918183765260228,2.2310416188743503
Cross-presentation of particulate exogenous antigens (phagosomes),0.08531129607996224,12.612257281553399,1.0689934600354087
Cyclin A-Cdk2-associated events at S phase entry,0.1619658412762598,2.8474063895568533,0.7905765688491597
Cyclin D-associated events in G1,0.3206966625110689,2.6513796627491053,0.4939055597490413
Cyclins and cell cycle regulation,0.21169960180366107,4.383706205149852,0.6742799588659699
Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway,0.0059800607864769675,20.27609756097561,2.223294401446815
Cytokine-cytokine receptor interaction,2.5496802194088415e-06,5.440283607024979,5.593514285313059
Cytoplasmic ribosomal proteins,0.6612724034622913,0.9297464940668824,0.1796196011038596
Cytoskeletal remodeling regulation and cell spreading by IPP complex components,0.08531129607996224,12.612257281553399,1.0689934600354087
Cytosolic DNA-sensing pathway,0.10861154661619028,3.678580931263858,0.9641240019559097
Cytosolic sensors of pathogen-associated DNA,0.19590881158612478,4.801664355062414,0.707946029869643
D4-GDI signaling pathway,0.00025099488255813507,30.563235294117646,3.6003351330983238
DARPP-32 events,0.0020762790538787854,13.28005115089514,2.682714277309507
DCC role in regulating apoptosis,0.10326293715496283,10.088834951456311,0.9860555262764817
DCC-mediated attractive signaling,0.0003935395273013253,25.46691176470588,3.405011640365359
Degradation of beta-catenin by the destruction complex,0.16544475872320355,2.8077235772357723,0.7813469867008418
Delta Np63 pathway,0.011789015084779876,6.780392156862745,1.9285224765938578
Deregulation of CDK5 in Alzheimer's disease,0.10326293715496283,10.088834951456311,0.9860555262764817
Dermatan sulfate biosynthesis,0.10326293715496283,10.088834951456311,0.9860555262764817
Destabilization of mRNA by AUF1 (hnRNP D0),0.4856007001543322,1.5244924977934688,0.31372069575293116
Destabilization of mRNA by butyrate response factor 1 (BRF1),0.1798032676389488,5.30761369443025,0.7452024199183122
Developmental biology,9.439373279727906e-14,7.417973284845094,13.025056839408636
Diabetes pathways,0.7462829009151477,0.7319112748919283,0.12709650896686214
Differentiation pathway in PC12 cells,0.0001953049856847798,7.826941243151332,3.7092866700365126
Dilated cardiomyopathy,0.0004968570764973513,6.50369206598586,3.303768520351546
Disease,1.416402300621752e-08,4.25676246830093,7.848813376501246
Dopamine receptors,0.05771112388474198,20.182524271844663,1.2387404680204133
Dorso-ventral axis formation,4.012121322061484e-06,25.709158415841582,5.396625942873656
Double stranded RNA-induced gene expression,0.12953506652101412,7.759522031366692,0.8876126475283884
Down syndrome cell adhesion molecule (DSCAM) interactions,0.11210683500664335,9.171226831421007,0.9503679082330622
Downregulation of ERBB2-ERBB3 signaling,0.12953506652101412,7.759522031366692,0.8876126475283884
Downregulation of SMAD2/3-SMAD4 transcriptional activity,0.001639880255060271,14.546218487394958,2.785187863211579
Downstream signaling events Of B cell receptor (BCR),5.649414152786202e-05,7.87538043478261,4.247996586411359
E-cadherin keratinocyte pathway,0.01962192192519719,10.133170731707319,1.7072584566589855
E-cadherin nascent AJ-like junctions pathway,4.406584713697897e-05,14.68033946251768,4.355897876435338
E2F transcription factor network,0.16893678475553764,2.769127965252255,0.7722757756690353
ECM-receptor interaction,1.9553980927694704e-06,10.815636624681852,5.708764812747458
EGF receptor (ErbB1) signaling pathway,5.3510452296371375e-08,25.060000000000002,7.27156137814202
EGF receptor transactivation by GPCRs in cardiac hypertrophy,1.4578263875352116e-09,30.919039642657733,8.836294193044722
EGF/EGFR signaling pathway,1.1029574086032766e-11,12.712844488188976,10.95744125779164
EGFR downregulation,0.030896686934087904,7.792495309568481,1.5100880876750074
EGFR interaction with phospholipase C-gamma,2.1222031591299894e-06,18.778833107191318,5.673213043306599
EGFR transactivation by gastrin,0.09433137905416296,11.210355987055015,1.0253438164545743
EGFR1 pathway,3.5994100646727444e-07,8.161864041391205,6.443768673302693
EPO receptor signaling,4.3467033071348294e-08,25.95625,7.361840002429727
ERBB signaling pathway,2.668488753887824e-14,20.2275390625,13.5737346231526
ERBB1 downstream pathway,2.8572533721263173e-12,16.145746281129867,11.544051246058535
ERBB1 internalization pathway,0.008168800412041021,7.82579185520362,2.0878417149096657
ERBB2 role in signal transduction and oncology,5.999360098166367e-06,23.36971197119712,5.221895069725645
ERBB2/ERBB3 signaling events,5.04366463461322e-06,15.885189437428243,5.297253798423106
ERBB4 signaling events,3.8867155274159584e-05,15.112842166569598,4.41041724465162
ERK activation,0.0014131258024276312,50.70487804878049,2.8498191737012464
ERK inactivation,6.1158847563469205e-06,45.50410509031199,5.2135407067381605
ERK1/ERK2 MAPK pathway,1.885970627205279e-12,23.634188034188035,11.724465075406751
ERK5 role in neuronal survival pathway,2.6821544993445803e-07,28.1831750339213,6.571516209228546
Effect of METS on macrophage differentiation,9.214010577854532e-07,36.737977369165485,6.035551293504956
Endochondral ossification,4.3052146215179745e-06,12.09425,5.36600519342807
Endocytosis,1.4108546582258758e-08,7.950336236357622,7.850517723582045
"Endocytotic role of NDK, phosphins and dynamin",0.16337672711675139,5.932609937178755,0.7868098082970303
Endogenous Toll-like receptor signaling,3.3779326970626227e-09,40.395833333333336,8.471349007691447
Endometrial cancer,9.38956520672756e-11,24.4953370322276,10.027354517711617
Endothelins,3.5043592906408975e-06,12.5125,5.455391373410511
Energy metabolism,0.0013733603733217551,9.085057471264367,2.8622154878111723
Energy-dependent regulation of mTOR by LKB1-AMPK,0.16337672711675139,5.932609937178755,0.7868098082970303
Ephrin receptor A forward pathway,4.1740252570887966e-11,36.30594405594405,10.379444927340257
Ephrin receptor B forward pathway,8.216747061228495e-09,18.130244755244753,8.085300081847537
Epidermal growth factor receptor (EGFR) pathway,1.4396385550850282e-08,11.497878359264497,7.841746530985186
Epithelial cell signaling in Helicobacter pylori infection,0.0005973020782224104,8.017094678217822,3.223805974188212
Epstein-Barr virus LMP1 signaling,7.010541172588568e-05,21.544205340938554,4.154248455756973
Erythrocyte differentiation pathway,0.01059504424944198,14.480139372822299,1.9748972251496615
Erythropoietin-mediated neuroprotection through NF-kB,0.11210683500664335,9.171226831421007,0.9503679082330622
Estrogen receptor signaling pathway,1.5867707193921872e-06,32.14263613861386,5.799485822140241
FAS pathway and stress induction of heat shock protein regulation,0.05906716756578286,5.328626444159178,1.2286538542656997
FGF signaling pathway,1.0070142629485506e-15,31.35038860103627,14.99696437822892
FGFR ligand binding and activation,2.4525237647616597e-09,42.77411764705882,8.610386775648381
FGFR1b ligand binding and activation,1.8471465403633214e-05,101.91176470588235,4.733498649147389
FGFR2b ligand binding and activation,3.20898391813754e-05,76.43014705882352,4.493632459371192
FGFR3 ligand binding and activation,6.1158847563469205e-06,45.50410509031199,5.2135407067381605
FGFR3b ligand binding and activation,0.002603730153358303,33.8,2.5844040273926656
FGFR4 ligand binding and activation,0.00031713089157646125,27.783422459893043,3.49876145148364
FOSB gene expression and drug abuse,0.05771112388474198,20.182524271844663,1.2387404680204133
FOXM1 transcription factor network,0.008168800412041021,7.82579185520362,2.0878417149096657
FRA pathway,1.8105037234227327e-06,19.36660447761194,5.742200577690226
FRS2-mediated activation,3.925756958924399e-05,25.58743842364532,4.406076590794406
FRS2-mediated cascade,4.562245762603934e-12,35.13197969543147,11.34082132351621
FSH regulation of apoptosis,6.577052653007338e-05,4.5563442768411715,4.181968681355126
FSH signaling pathway,7.245261108651564e-06,22.35256134309083,5.13994595857056
FYVE-finger proteins in vesicle transport,0.002603730153358303,33.8,2.5844040273926656
Factors involved in megakaryocyte development and platelet production,0.03624105894792724,3.338609383832674,1.4407991209145847
Fas signaling pathway,1.28322623364819e-10,13.460614553097788,9.891696770465623
Fas signaling pathway in cardiomyocytes,0.07620181512199029,14.414701803051319,1.1180346836725295
Fas signaling pathway in hepatocytes,0.06700205450091128,16.817961165048544,1.1739118802136672
"Fatty acid, triacylglycerol, and ketone body metabolism",0.8228621178152631,0.5785958808013918,0.0846729308736324
Fc epsilon receptor I signaling in mast cells,6.891202241406751e-09,24.545078332840674,8.161705004324448
Fc epsilon receptor I signaling pathway,1.4114867715188838e-05,9.934246575342465,4.85032318771421
Fc gamma receptor-mediated phagocytosis,4.3348141420465716e-05,8.234943181818181,4.363029518444741
Fibroblast growth factor 1,0.0023189739405441536,12.726102941176471,2.634704131716245
Fibroblast growth factor receptor pathway,1.4256757274578753e-13,17.77300824175824,12.845979244323184
Focal adhesion,5.541914005934779e-20,14.216160220994475,19.256340217463524
Folate metabolism,0.025336358180876595,4.9980713596914175,1.5962558099582682
FoxO family signaling,0.013169588727630412,6.491239048811013,1.8804277873851862
Free radical-induced apoptosis,0.10326293715496283,10.088834951456311,0.9860555262764817
Fructose and mannose metabolism,0.2931904246163953,2.9638777841233583,0.5328502175376227
G alpha (12/13) signaling events,0.17948564208304071,2.659435173299101,0.7459702869937775
G alpha (i) signaling events,0.5887959327712707,1.0147819660014783,0.2300351986384491
G alpha (s) signaling events,0.35317688123187874,1.6261998426435877,0.45200773284654816
G alpha (z) signaling events,0.07546301276121795,4.6006651884700664,1.1222658601547248
G alpha 12 pathway,2.9298876694257248e-08,19.862167982770995,7.533149029981636
G alpha 13 pathway,4.759483320366005e-06,11.895409836065575,5.322440190828505
G alpha i pathway,1.3436628478491522e-06,9.40590909090909,5.87170969087105
G alpha q pathway,0.005324339846974646,6.095434159252997,2.2737342317557196
G alpha s pathway,0.00019969567733627217,6.348815789473684,3.6996313358770307
G beta-gamma signaling through PI3K gamma,0.06700205450091128,16.817961165048544,1.1739118802136672
G-protein beta-gamma signalling,0.2498394144227854,3.6000346740638,0.602339046682321
G-protein signaling pathways,0.00037852495644730946,6.866666666666667,3.4219054818440857
G-protein-independent seven transmembrane receptor signaling,3.925756958924399e-05,25.58743842364532,4.406076590794406
G-protein-mediated events,0.0009958454766186438,9.973326925387482,3.0018080449680054
G1 to S cell cycle control,0.14478935493102213,3.063858093126386,0.8392633667622134
G13 signaling pathway,0.32740511109940934,2.5832710978342046,0.4849145451288914
GAB1 signalosome,2.4763122344239155e-06,18.225636523266026,5.606194596672072
GATA3-mediated activation of Th2 cytokine expression,0.0011012815371126941,16.973039215686274,2.9581016416237946
GM-CSF-mediated signaling events,1.5371966904322938e-06,19.99229658160809,5.8132705592379645
GPCR ligand binding,0.5794852565664113,0.9869645731714698,0.23695760900720936
GRB2-SOS provides linkage to MAPK signaling for integrins,2.518066173521277e-05,29.245601688951442,4.598932861036133
GRB7 events in ERBB2 signaling,0.05771112388474198,20.182524271844663,1.2387404680204133
Gamma-secretase-mediated ErbB4 signaling pathway,0.07620181512199029,14.414701803051319,1.1180346836725295
Gap junction pathway,3.282340566457379e-05,8.62875,4.483816359766858
Gastric acid secretion,0.0008746214806789256,7.327793493635077,3.0581798605999375
Gastrin pathway,1.2270345552420235e-08,22.55167730544615,7.911143206678361
Gastrin-CREB signaling pathway via PKC and MAPK,0.0010666414534842641,4.16029898234893,2.971981542095448
Gene expression,0.24898543067648957,1.2755244755244755,0.6038260647995428
Gene expression regulation in early pancreatic precursor cells,0.08531129607996224,12.612257281553399,1.0689934600354087
Gene expression regulation in pancreatic beta cells,0.017953197478093284,10.667008985879331,1.745858192020201
Generation of second messenger molecules,0.05140275642316432,5.786202090592334,1.289013591758171
Generic transcription pathway,0.012975837962891208,2.5158906134515893,1.8868645863959892
Ghrelin pathway,0.2271817603048409,4.032621359223302,0.6436265396729137
Glioma,9.090086231326235e-10,18.79713560551124,9.041431996908779
Glucagon signaling in metabolic regulation,0.044132317846072876,6.329573170731708,1.35524326264289
Gluconeogenesis,0.0037928215035731975,10.529411764705882,2.421037595429896
Glucose metabolism,0.023327921336680768,5.1679960119641075,1.6321239578298437
Glutamate binding and activation of AMPA receptors and synaptic plasticity,0.003462145004239394,10.905987394957982,2.460654746621737
Glutamate neurotransmitter release cycle,0.1550410986277819,6.303701456310679,0.8095531628533404
Glycogen metabolism,0.05140275642316432,5.786202090592334,1.289013591758171
Glycolysis,0.24236129059834613,3.733549083063646,0.615536743507379
Glycoprotein VI-mediated activation cascade,0.0003373050553248596,13.637438423645321,3.471977149818097
Glycosaminoglycan metabolism,0.02425973826164123,3.80940104046775,1.6151138890480985
GnRH signaling pathway,6.746339907375308e-08,11.421871551533878,7.170931781116199
Graft-versus-host disease,0.34062485634540973,2.45702107506512,0.4677236635379143
Granule cell survival pathway,6.024473502866288e-05,7.790322580645162,4.220080901415507
Growth hormone receptor signaling,1.2904964848266984e-11,30.99283368169603,10.88924317408985
HES/HEY pathway,0.012468296913788023,6.632672634271099,1.904192864200429
HIF-1 degradation in normoxia,0.0018825823684256449,6.102369165487977,2.725246013071399
HIF-1 transcriptional activity in hypoxia,0.00432998281453444,6.4836969270466795,2.3635138273343186
HIF-2-alpha transcription factor network,0.000377908639393755,13.196885428253616,3.4226131795353627
HIV factor interactions with host,0.13505197022445256,2.412114845938375,0.8694990756648576
HIV infection,0.3181914106277876,1.5296345811051695,0.49731154803105626
HIV-1 Nef as negative effector of Fas and TNF,0.0027328446628904707,7.429646215853111,2.5633850532567597
HIV-induced T cell apoptosis,0.09433137905416296,11.210355987055015,1.0253438164545743
HNF3A pathway,0.07263836187760435,4.707884288145207,1.1388339584784226
Heart development,5.04366463461322e-06,15.885189437428243,5.297253798423106
Hedgehog signaling pathway,0.0006810723063769993,7.773402340234023,3.1668067785518845
Hematopoietic cell lineage,2.8409761644825593e-05,8.840060975609756,4.546532409950814
Hemostasis pathway,4.717207406624422e-17,8.185515255292652,16.326315028233363
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) biosynthesis,0.003462145004239394,10.905987394957982,2.460654746621737
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) degradation,0.0011012815371126941,16.973039215686274,2.9581016416237946
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism,0.0018408156920652781,8.341811601487885,2.734989692172794
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis,0.007021709132644033,18.431929046563194,2.1535571647174363
Human cytomegalovirus and MAP kinase pathways,3.164979791586005e-05,27.29458128078818,4.499629058610513
Huntington's disease,0.27523670435580505,1.6654007756948934,0.5602936509733603
Hypertrophy pathway,0.18789577114699169,5.041990291262136,0.7260829941846972
Hypothetical network for drug addiction,1.6809609616251272e-05,18.35661244695898,4.7744423724306415
Hypoxia-inducible factor in the cardivascular system,0.1550410986277819,6.303701456310679,0.8095531628533404
ID regulation of gene expression,0.017953197478093284,10.667008985879331,1.745858192020201
IGF-1 receptor and longevity,3.925756958924399e-05,25.58743842364532,4.406076590794406
IGF1 pathway,3.7817770640277537e-10,37.95523069894929,9.422304076420719
IGF1 receptor signaling through beta-arrestin,4.927715544708037e-06,24.483734087694483,5.3073543700256955
IGF1 signaling pathway,5.580531987668909e-08,38.76305970149254,7.253324398141937
IKK complex recruitment by IRAK1,0.10326293715496283,10.088834951456311,0.9860555262764817
IKK complex recruitment mediated by RIP1,0.10326293715496283,10.088834951456311,0.9860555262764817
IRAK2-mediated activation of TAK1 complex,0.10326293715496283,10.088834951456311,0.9860555262764817
Immune system,8.41046226832502e-23,6.84365871470302,22.075180133207397
"Immune system signaling by interferons, interleukins, prolactin, and growth hormones",5.583391910489074e-18,11.569450763730906,17.253101887000163
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell,0.33167466044485683,1.7093840429929723,0.4792877068023141
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages,1.7574837739569164e-08,30.288125,7.755108675931754
Induction of apoptosis through DR3 and DR4/5 death receptors,0.046510171538009355,6.137472283813747,1.3324520587281412
Inflammasomes,0.16337672711675139,5.932609937178755,0.7868098082970303
Inflammatory response pathway,0.26457600536198,3.3597087378640773,0.5774495449232956
Influence of Ras and Rho proteins on G1 to S transition,0.00020556024476718675,15.738537324744224,3.687060873858166
Inhibition of T cell receptor signaling by activated Csk,0.1798032676389488,5.30761369443025,0.7452024199183122
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP,5.999360098166367e-06,23.36971197119712,5.221895069725645
Inhibition of cellular proliferation by Gleevec,4.012121322061484e-06,25.709158415841582,5.396625942873656
Inhibition of platelet activation by aspirin,0.0005796553976107903,21.826680672268907,3.2368301157353905
Initiation of the second proteolytic cleavage of Notch receptor by receptor-ligand binding,0.13812108773659357,7.204923717059638,0.859740010136222
Innate immune system,4.674090926413923e-10,6.880398671096345,9.33030284340812
Inositol phosphate metabolism,0.11179117506110066,3.6127177700348434,0.9515924788605007
Insulin receptor substrate (IRS) activation,0.0014131258024276312,50.70487804878049,2.8498191737012464
Insulin regulation of blood glucose,7.245261108651564e-06,22.35256134309083,5.13994595857056
Insulin secretion regulation by glucagon-like peptide-1,0.0698491949617175,4.8202090592334494,1.1558385949284475
Insulin signaling pathway,4.979186775349091e-17,11.151891586674195,16.302841582505003
Integrated breast cancer pathway,2.939912258033744e-06,7.330233218558092,5.531665630955328
Integrated cancer pathway,0.048934027113213145,5.956671449067431,1.3103890417287622
Integration of energy metabolism,0.12838916145802715,2.471305595408895,0.8914716376195899
Integrin alpha-2b beta-3 signaling,0.002603730153358303,33.8,2.5844040273926656
Integrin beta-2 pathway,0.25724407997113713,3.4757281553398056,0.5896546109890537
Integrin beta-5 pathway,0.013335414315298676,12.66890243902439,1.8749934867567992
Integrin cell surface interactions,1.7617549530204715e-07,12.229043683589136,6.754054498847901
Integrin family cell surface interactions,0.00013471996055583154,17.793960162775754,3.870568052999913
Integrin signaling pathway,4.374991418428202e-07,7.9918367346938775,6.359022794512053
Integrin-linked kinase signaling,8.750042198995208e-05,12.528374788698383,4.057989852492365
Integrin-mediated cell adhesion,6.137141264043493e-08,11.547944441345456,7.212033880058336
Integrins in angiogenesis,3.3068485586132245e-09,16.187426786411557,8.480585693705772
Interferon alpha signaling regulation,0.0020762790538787854,13.28005115089514,2.682714277309507
Interferon alpha/beta signaling,0.026374402164942447,4.917220113851992,1.5788173758424664
Interferon gamma signaling regulation,0.0003935395273013253,25.46691176470588,3.405011640365359
Interferon signaling,0.0014664024314352928,4.457314814814815,2.8337468279435107
Interferon-beta enhancer pathway,0.03728631824585162,6.985365853658537,1.4284504979594466
Interferon-gamma signaling pathway,3.4660784447059796e-09,13.35714285714286,8.460161612505708
Interleukin receptor SHC signaling,0.2498394144227854,3.6000346740638,0.602339046682321
Interleukin-1 processing,0.002603730153358303,33.8,2.5844040273926656
Interleukin-1 regulation of extracellular matrix,3.407056106038962e-07,9.458087529153518,6.467620714585192
Interleukin-1 signaling pathway,1.9042295758523236e-12,14.556587837837839,11.720280693811091
Interleukin-1-beta (IL-1b) processing pathway,0.06700205450091128,16.817961165048544,1.1739118802136672
Interleukin-11 pathway,9.902654249085612e-08,34.45273631840796,7.004248384065807
Interleukin-12-mediated signaling events,0.02743496364525258,4.838935574229692,1.561695610961857
Interleukin-12/STAT4 pathway,0.010496042438106524,7.096443228454172,1.9789744220044072
Interleukin-17 signaling pathway,0.14662282396907042,6.724271844660194,0.8337984201977292
Interleukin-2 receptor beta chain in T cell activation,9.38956520672756e-11,24.4953370322276,10.027354517711617
Interleukin-2 signaling pathway,1.1158306713315593e-16,5.924290033793798,15.952401705116925
Interleukin-2/PI3K pathway,0.00530462675954487,9.251336898395722,2.27534516821365
Interleukin-2/STAT5 pathway,0.26457600536198,3.3597087378640773,0.5774495449232956
Interleukin-22 soluble receptor signaling pathway,0.12953506652101412,7.759522031366692,0.8876126475283884
Interleukin-23-mediated signaling events,0.053915248898783776,5.62520325203252,1.2682883855371394
Interleukin-3 regulation of hematopoietic cells,0.017953197478093284,10.667008985879331,1.745858192020201
Interleukin-3 signaling pathway,1.4728720275828695e-08,21.95715419201269,7.831834985763613
"Interleukin-3, interleukin-5, and GM-CSF signaling",8.750042198995208e-05,12.528374788698383,4.057989852492365
Interleukin-4 regulation of apoptosis,7.523676037366985e-05,4.484554911458747,4.123569913043632
Interleukin-4 signaling pathway,8.905612355625027e-08,11.059577878706918,7.05033621280652
Interleukin-5 regulation of apoptosis,1.1222340906311921e-12,13.418726409351029,11.949916542665056
Interleukin-5 signaling pathway,1.3035615381184173e-09,23.006651884700666,8.88486846197596
Interleukin-6 regulation of target genes,0.13812108773659357,7.204923717059638,0.859740010136222
Interleukin-6 signaling pathway,2.1946962793167482e-09,16.973145570656623,8.658625572617016
Interleukin-7 interactions in immune response,0.2931904246163953,2.9638777841233583,0.5328502175376227
Interleukin-7 signaling pathway,5.518175702392406e-11,34.95959595959596,10.258204475410905
Interleukin-9 regulation of target genes,0.0023189739405441536,12.726102941176471,2.634704131716245
Interleukin-9 signaling pathway,0.011930429429686152,13.514146341463414,1.923343923841263
Intestinal immune network for IgA production,0.08414032028848041,4.306382978723404,1.0749958391308252
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,0.011930429429686152,13.514146341463414,1.923343923841263
JNK/MAPK pathway,9.769865417573911e-07,15.449148936170213,6.0101114187589735
Jak-STAT signaling pathway,5.004976852212632e-06,6.118237771298995,5.300597926771989
KIT signaling regulation,4.982752468756895e-07,42.86509900990099,6.302530687005773
Keap1-Nrf2 pathway,0.12953506652101412,7.759522031366692,0.8876126475283884
Keratinocyte differentiation,9.929935599361108e-12,24.772687798523666,11.003053568114165
Kit receptor signaling pathway,1.3845345496986696e-10,23.404399323181046,9.85869620239131
Kit receptor transcriptional targets,0.05771112388474198,20.182524271844663,1.2387404680204133
Klotho-mediated ligand binding,0.06700205450091128,16.817961165048544,1.1739118802136672
L1CAM interactions,3.3976544479282927e-08,12.366676619886535,7.468820792326613
LKB1 signaling events,4.270115219284283e-07,17.715121951219512,6.369560406374444
LPA receptor mediated events,4.373157841495259e-11,21.16122448979592,10.359204847271355
LPA4-mediated signaling events,0.1550410986277819,6.303701456310679,0.8095531628533404
Latent infection of Homo sapiens with Mycobacterium tuberculosis,0.31392163042915083,2.723169771713461,0.5031787586791449
Lck and Fyn tyrosine kinases in initiation of T cell receptor activation,0.12953506652101412,7.759522031366692,0.8876126475283884
Leishmaniasis,1.3643239792140012e-10,18.76571757735352,9.865082487687149
Leptin influence on immune response,0.0008184599197407366,5.881449893390191,3.0870025832790757
Leptin signaling pathway,9.53064116061804e-09,17.78730703259005,8.020877881822118
Leukocyte transendothelial migration,0.0001709366660751763,6.521351351351351,3.7671647707131015
Lipid and lipoprotein metabolism,0.2106025264081278,1.4717391304347824,0.6765364232809795
"Lipid digestion, mobilization, and transport",0.08414032028848041,4.306382978723404,1.0749958391308252
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha),0.6745003452414129,0.896367891816921,0.17101782369941249
Long-term depression,0.005324339846974646,6.095434159252997,2.2737342317557196
Long-term potentiation,6.368148072941018e-06,11.336171875,5.195986846885721
MAL role in Rho-mediated activation of SRF,0.01634825310276179,11.260162601626016,1.7865286471849426
MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35,0.00031713089157646125,27.783422459893043,3.49876145148364
MAP kinase inactivation of SMRT corepressor,0.00933076950290206,15.594746716697937,2.0300825387740216
MAP kinase pathway regulation through dual specificity phosphatases,2.1466174079149367e-08,102.91089108910892,7.668245353066145
MAP kinase signaling pathway,8.038405634835839e-09,14.608714043993231,8.09483008217907
MAPK cascade role in angiogenesis,3.5043592906408975e-06,12.5125,5.455391373410511
MAPK signaling pathway,1.1608602015704536e-26,14.907703488372094,25.935220077713755
MAPK/TRK pathway,2.262727879092318e-05,17.13118811881188,4.645367672167529
MEF2D role in T cell apoptosis,0.0004218887944667096,12.783866995073891,3.374802009498191
MEK activation,0.07620181512199029,14.414701803051319,1.1180346836725295
MSP/RON receptor signaling pathway,0.06700205450091128,16.817961165048544,1.1739118802136672
Malaria,1.8818986152095468e-09,21.93446088794926,8.725403777317409
Mammalian calpain regulation of cell motility,2.6821544993445803e-07,28.1831750339213,6.571516209228546
Mammalian target of rapamycin complex 1 (mTORC1)-mediated signaling,0.11210683500664335,9.171226831421007,0.9503679082330622
Maturity onset diabetes of the young,0.2271817603048409,4.032621359223302,0.6436265396729137
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha,1.6043199228046668e-06,14.234705882352943,5.794709023299695
Mechanisms of transcriptional repression by DNA methylation,0.14662282396907042,6.724271844660194,0.8337984201977292
Meiosis,0.5655892939654873,1.211252778102702,0.24749881988958258
Meiotic recombination,0.4204699387447968,1.8643473570658036,0.3762650483891087
Melanocyte development and pigmentation pathway,8.496182824273008e-06,40.95172413793103,5.070776150839037
Melanogenesis,6.746339907375308e-08,11.421871551533878,7.170931781116199
Melanoma,1.1204254944021993e-17,31.020194465220637,16.950617017706175
Metabolism,0.999722702990574,0.2947250032265797,0.00012044526136928185
MicroRNA regulation of DNA damage response,0.15504975395891565,2.930222693531283,0.8095289185873774
MicroRNAs in cardiomyocyte hypertrophy,2.628718055940554e-12,19.019912441745515,11.580255991799884
MicroRNAs in muscle cell differentiation,5.114259580531042e-07,24.797611940298506,6.291217232600022
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family,5.731728374484084e-06,9.247571189279734,5.241714398919815
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family,0.001639880255060271,14.546218487394958,2.785187863211579
Mitochondrial pathway of apoptosis: caspases,0.007411641912474219,5.516975103182,2.130085571435335
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family,0.034268909754731805,4.41687979539642,1.4650997121746174
Mitotic G1-G1/S phases,0.3884511843733769,1.5041135784492172,0.41066355006593314
Mitotic G2-G2/M phases,0.05633591533478203,3.5826989619377163,1.2492146449589343
Modulation of interferon signaling by chaperones,0.21169960180366107,4.383706205149852,0.6742799588659699
Monoamine transport,0.004897731929121692,9.540900735294118,2.3100049890947765
Monocyte and its surface molecules,0.0059800607864769675,20.27609756097561,2.223294401446815
Mu-calpain pathway,0.01059504424944198,14.480139372822299,1.9748972251496615
Multi-step regulation of transcription by PITX2,0.002855343104681965,11.746040723981901,2.5443416984454075
Muscle contraction,0.08709743410351585,4.216463414634146,1.0599946391496102
Myc active pathway,0.0532812256136482,3.669383416017009,1.2734257937641367
Myc repressed pathway,0.03672481318628128,4.292046396023198,1.4350404047241876
Myocyte adrenergic pathway,0.005874330555353722,5.918183765260228,2.2310416188743503
Myometrial relaxation and contraction pathways,4.895147103567248e-10,10.549295774647888,9.310234252725483
N-cadherin signaling events,0.004897731929121692,9.540900735294118,2.3100049890947765
NADE-dependent death signaling,0.06700205450091128,16.817961165048544,1.1739118802136672
NCAM signaling for neurite out-growth,6.368148072941018e-06,11.336171875,5.195986846885721
NCAM1 interactions,0.3599711738490688,2.2891659311562225,0.4437322757313986
NF-kappaB activation,0.001965540187726133,40.5619512195122,2.7065180721037385
NF-kappaB activation by non-typeable Hemophilus influenzae,0.0002656055106793029,14.61294862772695,3.575762918638412
NF-kappaB signaling pathway,9.861600713492575e-05,19.490499648135117,4.006052585605062
NFAT involvement in hypertrophy of the heart,2.8543560540126907e-08,15.448584202682563,7.54449185369926
NGF signaling via TRKA from the plasma membrane,3.012363268839079e-14,15.414078947368422,13.521092656595112
NOD signaling pathway,0.00020824935033246587,7.728731343283581,3.681416344770948
Natural killer cell receptor signaling pathway,2.27038639011289e-06,13.441944444444443,5.643900225267762
Natural killer cell-mediated cytotoxicity,9.445739080102595e-06,7.281183932346724,5.0247640551214525
Nectin adhesion pathway,0.00023420199241846692,15.154898741105637,3.6304094145895944
Nef in HIV-1 replication and disease pathogenesis,0.032973823514043946,7.503523035230352,1.4818306908679861
Nef-induced signal transduction,0.08531129607996224,12.612257281553399,1.0689934600354087
Negative regulation of FGFR signaling,1.9679385286195048e-10,29.49005681818182,9.705988471503405
Negative regulation of the PI3K/Akt network,0.07620181512199029,14.414701803051319,1.1180346836725295
Nephrin interactions,0.20384316548076056,4.5831862312444835,0.6907038451328491
Nerve growth factor (NGF) pathway,1.5867707193921872e-06,32.14263613861386,5.799485822140241
Netrin mediated repulsion signals,0.00014693000911407704,38.2077205882353,3.83288949446403
Netrin-1 signaling,0.0008375980792066875,10.485790071996968,3.0769643272591245
Netrin-mediated signaling events,7.567924602543133e-07,22.958540630182423,6.121023203358718
Neural crest differentiation,3.565733461494344e-06,9.910983488872935,5.4478511234513265
Neuroactive ligand-receptor interaction,0.05390175291413534,2.2948180446084185,1.2683971110923438
Neuronal system,0.0628082283522944,2.202834747127671,1.2019834566783005
Neurophilin interactions with VEGF and VEGF receptor,0.05771112388474198,20.182524271844663,1.2387404680204133
Neuroregulin receptor degredation protein-1 controls ErbB3 receptor recycling,1.8471465403633214e-05,101.91176470588235,4.733498649147389
Neurotransmitter release cycle,0.3070793572309832,2.798948220064725,0.5127493771160211
Neurotrophic factor-mediated Trk receptor signaling,6.96744622003467e-13,26.052119309262167,12.156926374811619
Neurotrophin signaling pathway,4.6223895405850276e-27,29.429024670422848,26.335133458208286
Nicotine activity on dopaminergic neurons,0.01962192192519719,10.133170731707319,1.7072584566589855
Nicotinic acetylcholine receptor role in the regulation of apoptosis,0.014808510799766276,11.923098995695838,1.8294886135897137
Nifedipine activity,0.05771112388474198,20.182524271844663,1.2387404680204133
Nitric oxide effects,0.09433137905416296,11.210355987055015,1.0253438164545743
Nitric oxide signaling pathway,2.582102333375275e-06,28.56848184818482,5.588026549854451
Nitric oxide stimulation of guanylate cyclase,0.2498394144227854,3.6000346740638,0.602339046682321
"Non-class A, B, C GPCRs",0.2116579729220212,2.3768149210903875,0.6743653674884753
Non-small cell lung cancer,1.6539514413821685e-05,12.637222053000304,4.781477245115602
Notch signaling pathway,0.00021010605852809705,6.293304347826087,3.6775614242842676
NrCAM interactions,0.002603730153358303,33.8,2.5844040273926656
Nuclear beta-catenin signaling and target gene transcription regulation,0.00014972948114840603,8.245970149253731,3.8246926803549393
Nuclear events mediated by MAP kinases,5.054288019663109e-10,36.30325540747214,9.296340013348773
Nuclear receptor transcription pathway,0.0017149603042551848,8.516009852216749,2.7657459280074774
Nuclear receptors,0.006644744175368632,8.479166666666666,2.1775217348663904
Nuclear receptors in lipid metabolism and toxicity,0.046510171538009355,6.137472283813747,1.3324520587281412
Nuclear signaling by ErbB4,0.007639995849438494,8.032120743034056,2.116906877362327
Nucleotide G-protein coupled receptors (GPCRs),0.007021709132644033,18.431929046563194,2.1535571647174363
"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.011789015084779876,6.780392156862745,1.9285224765938578
Nucleotide-like (purinergic) G-protein coupled receptors,0.011930429429686152,13.514146341463414,1.923343923841263
Olfactory transduction,0.42417419405430284,1.1777667252706578,0.37245575666039854
Oncostatin M,4.064713837961728e-11,7.508973701560325,10.390970023985965
Oocyte meiosis,1.735193406327638e-08,11.273528829007331,7.760652111294095
Opioid signaling,0.008450238025173393,5.301260316038642,2.07313105772919
Osteoblast signaling,0.00933076950290206,15.594746716697937,2.0300825387740216
Osteoclast signaling,0.16337672711675139,5.932609937178755,0.7868098082970303
Osteopontin signaling,0.00019448434460387636,33.96078431372549,3.7111153523115004
Ovarian infertility genes,0.03728631824585162,6.985365853658537,1.4284504979594466
Oxidative stress,0.00015596574379702822,17.051724137931032,3.8069707792969454
Oxidative stress-induced gene expression via Nrf2,2.037054660426158e-06,30.250436808386723,5.690997317390133
PAC1 receptor pathway,0.0006979677714512679,11.053654639861536,3.156164630391189
PD-1 signaling,0.27183590172757066,3.2511744440964607,0.5656931859681069
PDGFA signaling pathway,5.114259580531042e-07,24.797611940298506,6.291217232600022
PDGFB signaling pathway,7.108623316804042e-16,17.5858843537415,15.148214498258424
PELP1 modulation of estrogen receptor activity,0.002603730153358303,33.8,2.5844040273926656
PGC-1a regulation,0.0023189739405441536,12.726102941176471,2.634704131716245
PI3K cascade,2.407405485537878e-10,21.93845177664975,9.618450754220085
PI3K class IB pathway,0.008139138839488623,16.89512195121951,2.0894215431504537
PI3K class IB pathway in neutrophils,4.407155557624459e-06,16.304006284367635,5.355841620099197
PI3K events in ERBB2 signaling,5.04366463461322e-06,15.885189437428243,5.297253798423106
PI3K pathway,9.769865417573911e-07,15.449148936170213,6.0101114187589735
PI3K/AKT activation,0.0005206080046842264,12.03071573456969,3.2834891586173653
PI3K/PLC/TRK pathway,2.990024289131643e-05,16.058941831683168,4.5243252837180465
PIK3C1/AKT pathway,2.6067398810115872e-05,16.577770680293835,4.583902303652348
PIK3C1/B pathway,0.001965540187726133,40.5619512195122,2.7065180721037385
PIP biosynthesis at the plasma membrane,0.044132317846072876,6.329573170731708,1.35524326264289
PIP2 hydrolysis,0.026906925653485875,8.442682926829269,1.5701359212626682
PKA activation in glucagon signaling,0.014808510799766276,11.923098995695838,1.8294886135897137
PKA-mediated phosphorylation of key metabolic factors,1.8471465403633214e-05,101.91176470588235,4.733498649147389
PKB-mediated events,0.2498394144227854,3.6000346740638,0.602339046682321
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,0.01962192192519719,10.133170731707319,1.7072584566589855
PP2A-mediated dephosphorylation of key metabolic factors,0.07620181512199029,14.414701803051319,1.1180346836725295
PPAR signaling pathway,0.5007112182484498,1.457999155761925,0.3004126782858921
PPAR-gamma coactivator role in obesity and thermogenesis,0.09433137905416296,11.210355987055015,1.0253438164545743
PTEN-dependent cell cycle arrest and apoptosis,1.2187112223242803e-06,34.28712871287129,5.914099189712697
Pancreatic beta-cell development regulation,0.004142111435261719,10.177941176470588,2.382778221456991
Pancreatic cancer,1.906109765629236e-09,17.25222601314804,8.719852093606155
Pathogenic Escherichia coli infection,0.01958195015869772,5.544919786096256,1.7081440591627846
Pathways in cancer,3.7370216658753024e-32,17.17432268330472,31.427474384263604
Pertussis toxin-insensitive CCR5 signaling in macrophage,0.0008140941973240391,19.096507352941178,3.0893253407973162
Phagosome,0.018875990711718783,3.406435643564356,1.724090245031688
Phosphatidylinositol metabolism,0.09008537069174385,4.1302140368342455,1.0453457300387008
Phosphatidylinositol signaling system,0.04324804015428321,4.008707430340557,1.3640335684180207
Phosphoinositides and their downstream targets,0.026906925653485875,8.442682926829269,1.5701359212626682
Phospholipase C epsilon pathway,0.007021709132644033,18.431929046563194,2.1535571647174363
Phospholipase C signaling pathway,0.10326293715496283,10.088834951456311,0.9860555262764817
Phospholipase C-mediated cascade,1.3845345496986696e-10,23.404399323181046,9.85869620239131
Phospholipid metabolism,0.14666363784816155,2.0085841096424915,0.833677546956742
Phospholipids as signaling intermediaries,1.5371966904322938e-06,19.99229658160809,5.8132705592379645
Phototransduction,0.03510411352058633,7.2351916376306615,1.4546419896704321
Physiological and pathological hypertrophy  of the heart,0.00013471996055583154,17.793960162775754,3.870568052999913
Plasma membrane estrogen receptor signaling,0.34062485634540973,2.45702107506512,0.4677236635379143
"Platelet activation, signaling and aggregation",2.371711512045045e-10,9.083714521906861,9.624938138388087
Platelet adhesion to exposed collagen,0.12953506652101412,7.759522031366692,0.8876126475283884
Platelet aggregation (plug formation),1.8105037234227327e-06,19.36660447761194,5.742200577690226
Platelet endothelial cell adhesion molecule 1 (PECAM1) interactions,6.1158847563469205e-06,45.50410509031199,5.2135407067381605
Platelet homeostasis,0.197275945345781,2.4946702800361336,0.7049258668029331
Platelet sensitization by LDL,0.16337672711675139,5.932609937178755,0.7868098082970303
Plexin D1 signaling,0.024996875915054558,8.8101802757158,1.6021142656332958
Polo-like kinase 1 (PLK1) pathway,0.3725538250890183,2.1894259181089066,0.4288109732500881
Polo-like kinase 3 (PLK3) pathway,0.05771112388474198,20.182524271844663,1.2387404680204133
Post-translational regulation of adherens junction stability and disassembly,1.3727877215450158e-12,30.653195488721803,11.862396613884277
Pre-NOTCH expression and processing,0.11179117506110066,3.6127177700348434,0.9515924788605007
Presenilin action in Notch and Wnt signaling,4.095010494387561e-11,27.01288559156579,10.387744980924621
Prion diseases,1.2985346719284832e-06,20.659701492537316,5.886546449865108
Prion pathway,0.01962192192519719,10.133170731707319,1.7072584566589855
Progesterone-initiated oocyte maturation,0.001639880255060271,14.546218487394958,2.785187863211579
Progesterone-mediated oocyte maturation,2.449660300621967e-05,9.061937499999999,4.610894135959559
Prolactin activation of MAPK signaling,9.236267853907707e-19,31.443175735950046,18.034503480931637
Prolactin receptor signaling pathway,0.01059504424944198,14.480139372822299,1.9748972251496615
Prolactin regulation of apoptosis,2.3944546619912108e-05,7.4904250984653,4.620793381729934
Prostate cancer,2.458670783314295e-13,19.773520589037357,12.609299619517426
Protein kinase A (PKA) at the centrosome,0.1550410986277819,6.303701456310679,0.8095531628533404
Protein processing in the endoplasmic reticulum,0.8100350640465284,0.6031992045853316,0.09149618137773877
Proteins and DNA sequences in cardicac structures,0.0025785349241538085,12.216470588235293,2.5886269820526633
Proteolysis and signaling pathway of Notch,0.06700205450091128,16.817961165048544,1.1739118802136672
Purine metabolism,0.8062032815699788,0.6106144920672507,0.09355543842703455
RAC1 activity regulation,0.006644744175368632,8.479166666666666,2.1775217348663904
RAGE pathway,0.022357560558947564,5.25735294117647,1.6505755842195857
RANKL regulation of apoptosis and immune response,9.755843755397042e-05,8.965606748864374,4.0107351637408675
RANKL signaling pathway,6.370103296739856e-08,17.74489468619694,7.195853525146536
RIG-I-like receptor signaling pathway,0.5105386561238436,1.41679201422125,0.29197136913888755
RIG-I/MDA5-mediated induction of interferon-alpha/beta pathways,0.5342731834763019,1.3232626469085333,0.27223662360960543
RNA polymerase I promoter opening,0.27183590172757066,3.2511744440964607,0.5656931859681069
RNA polymerase I transcription,0.4261974499732443,1.8303618711385703,0.37038915308700165
"RNA polymerase I, RNA polymerase III, and mitochondrial transcription",0.6144748133281146,1.057639243740419,0.21149591368361606
RSK activation,0.001965540187726133,40.5619512195122,2.7065180721037385
RXR/VDR pathway,0.028873961790521197,8.104585365853659,1.539493622571793
Rac1 cell motility signaling pathway,0.0007261094945246084,7.657011969853701,3.138997884420759
Rap1 signaling,0.0005796553976107903,21.826680672268907,3.2368301157353905
Ras activation upon calcium influx through NMDA receptor,0.0009508300728066499,17.972318339100347,3.021897090882179
Ras family activation regulation,0.03951921802867018,6.752195121951219,1.4031916574344458
Ras signaling pathway,0.0023189739405441536,12.726102941176471,2.634704131716245
Ras-independent pathway in NK cell-mediated cytotoxicity,9.861600713492575e-05,19.490499648135117,4.006052585605062
Recycling pathway of cell adhesion molecule L1,0.032973823514043946,7.503523035230352,1.4818306908679861
Reelin signaling pathway,0.00020556024476718675,15.738537324744224,3.687060873858166
Regular glucocorticoid receptor pathway,1.2917605971981542e-07,12.726658476658477,6.888817966952184
Regulated proteolysis of p75 neurotrophin receptor,0.00019448434460387636,33.96078431372549,3.7111153523115004
Regulation of NFAT transcription factors,8.875669279002237e-10,24.18881118881119,9.051798888614465
Regulation of transcription by NOTCH1 intracellular domain,0.37875252495092715,2.142739103491014,0.4216444632590126
Renal cell carcinoma,1.906109765629236e-09,17.25222601314804,8.719852093606155
Renin-angiotensin system,0.16337672711675139,5.932609937178755,0.7868098082970303
Repression of pain sensation by the transcriptional regulator DREAM,3.5456047981316143e-07,46.764176417641764,6.450309673573143
Response to elevated platelet cytosolic calcium,0.001456720881346293,6.490161674395288,2.8366236543409644
Retinoblastoma protein regulation,0.00432998281453444,6.4836969270466795,2.3635138273343186
Retinoic acid receptor-mediated signaling,0.00023420199241846692,15.154898741105637,3.6304094145895944
Rho GTPase cycle,0.3460342035771208,1.6530187924830069,0.46088097146548457
Rho cell motility signaling pathway,0.21169960180366107,4.383706205149852,0.6742799588659699
RhoA activity regulation,0.3725538250890183,2.1894259181089066,0.4288109732500881
RhoA signaling pathway,0.010496042438106524,7.096443228454172,1.9789744220044072
S phase,0.30634781758520085,1.8177982860909692,0.5137852092248968
S1P/S1P1 pathway,5.8362227483709924e-05,22.742200328407225,4.2338681409488625
S1P/S1P3 pathway,1.0338605836690756e-05,20.562376237623763,4.985538022001712
S1P/S1P4 pathway,0.00933076950290206,15.594746716697937,2.0300825387740216
S6K1 signaling,0.08531129607996224,12.612257281553399,1.0689934600354087
SHC-related events,2.518066173521277e-05,29.245601688951442,4.598932861036133
SHC1 events in EGFR signaling,1.4349004073909805e-08,51.694029850746276,7.8431782411052655
SHC1 events in ERBB2 signaling,1.666255869459615e-07,31.004477611940295,6.778258307753968
SHP2 signaling,1.2132222790609622e-14,30.896219931271474,13.916059623102226
SIDS susceptibility pathways,0.14478935493102213,3.063858093126386,0.8392633667622134
SLC-mediated transmembrane transport,0.9188485128574928,0.39728464781650097,0.036756083230919355
SMAD2/3 nuclear pathway,1.7993734723681365e-05,9.540723684210525,4.74487868648496
SRF and microRNAs in smooth muscle differentiation and proliferation,0.12086392882947664,8.406553398058252,0.9177032925860766
STAT3 pathway,0.01634825310276179,11.260162601626016,1.7865286471849426
SUMOylation as a mechanism to modulate CtBP-dependent gene responses,0.11210683500664335,9.171226831421007,0.9503679082330622
Salivary secretion,0.001977620109620134,6.030285381479324,2.70385713040365
Second messenger role in netrin-1 signaling,0.10326293715496283,10.088834951456311,0.9860555262764817
Segmentation clock,0.0023189739405441536,12.726102941176471,2.634704131716245
Selective expression of chemokine receptors during T-cell polarization,0.2348089833246225,3.877333831217326,0.6292852918635983
Selenium metabolism and selenoproteins,0.0005796553976107903,21.826680672268907,3.2368301157353905
Selenium pathway,0.022357560558947564,5.25735294117647,1.6505755842195857
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion,0.13812108773659357,7.204923717059638,0.859740010136222
Sema3A/PAK-dependent axon repulsion,0.14662282396907042,6.724271844660194,0.8337984201977292
Sema4D in semaphorin signaling,0.25724407997113713,3.4757281553398056,0.5896546109890537
Sema4D-mediated inhibition of cell attachment and migration,0.08531129607996224,12.612257281553399,1.0689934600354087
Semaphorin interactions,0.02851800962169252,4.763097426470589,1.5448807887949387
Senescence and autophagy,0.0031304834815740162,5.392912975508077,2.504388583487292
Serotonin HTR1 group and FOS pathway,0.041801612002438454,6.534067663257278,1.378806970132502
Serotonin receptor 2 and ELK-SRF/GATA4 signaling,0.1550410986277819,6.303701456310679,0.8095531628533404
Serotonin receptor 4/6/7 and NR3C signaling,0.1716305169121396,5.602750809061488,0.7654054895163487
Serotonin transporter activity,0.0059800607864769675,20.27609756097561,2.223294401446815
Seven transmembrane receptor signaling through beta-arrestin,9.755843755397042e-05,8.965606748864374,4.0107351637408675
Shigellosis,0.00039182059876624874,8.8490099009901,3.4069127360407228
Signal attenuation,8.496182824273008e-06,40.95172413793103,5.070776150839037
Signal regulatory protein (SIRP) family interactions,2.3988458406419037e-09,77.55597014925374,8.61999766062315
Signal transduction,9.595943164241687e-21,6.324093608376308,20.017912332976955
Signal transduction by L1,1.8585819962527246e-09,29.813352476669056,8.730818274097684
Signal transduction of S1P receptor,9.861600713492575e-05,19.490499648135117,4.006052585605062
Signal transduction through IL-1R,9.615682703282169e-08,22.70734375,7.017019875882851
Signal-dependent regulation of myogenesis by corepressor MITR,0.005015798046164786,22.530081300813006,2.299659958062889
Signaling by EGFR,0.001965540187726133,40.5619512195122,2.7065180721037385
Signaling by EGFR in cancer,8.201520466467023e-11,14.007185254607935,10.086105627008479
Signaling by ERBB2,2.7922419809298528e-11,15.414604810996561,10.554046947643167
Signaling by ERBB4,1.4376570847939184e-10,15.54296435272045,9.842344691103037
Signaling by FGFR in disease,1.775175572672577e-13,15.330584256127507,12.750758686850011
Signaling by FGFR mutants,3.1563693818348994e-07,18.625384615384615,6.500812178116152
Signaling by FGFR1 mutants,1.2228448121044145e-05,19.77056359482102,4.91262865459342
Signaling by GPCR,0.017014227979702094,1.8464538036037021,1.769187752225647
Signaling by Hippo,0.18789577114699169,5.041990291262136,0.7260829941846972
Signaling by NGF,3.073499627857819e-18,13.641331346249379,17.5123668351279
Signaling by NODAL,0.1798032676389488,5.30761369443025,0.7452024199183122
Signaling by NOTCH,0.031106240703164735,3.512315270935961,1.5071524717110532
Signaling by NOTCH1,0.16544475872320355,2.8077235772357723,0.7813469867008418
Signaling by PDGF,3.97130492688638e-07,9.289789317640718,6.401066765421655
Signaling by Robo receptor,0.279024473281481,3.1494235436893208,0.554357703016836
Signaling by SCF-KIT,8.466986572234321e-13,21.04428303655108,12.072271128973965
Signaling by TGF-beta receptor complex,0.0005215062347677258,8.276509102523155,3.282740495082065
Signaling by VEGF,0.00019448434460387636,33.96078431372549,3.7111153523115004
Signaling by activated point mutants of FGFR1,6.638874238112622e-08,73.50070721357851,7.177905558226259
Signaling by constitutively active EGFR,0.01634825310276179,11.260162601626016,1.7865286471849426
Signaling by insulin receptor,2.4977410218343355e-13,17.021381578947366,12.602452593431439
Signaling by interleukins,1.4503753410602829e-18,22.99146598082768,17.838519592622205
Signaling by the B cell receptor (BCR),2.0526367115380914e-05,6.563890654799747,4.687687907977412
Signaling events mediated by HDAC class I,0.005324339846974646,6.095434159252997,2.2737342317557196
Signaling events mediated by HDAC class II,0.3206966625110689,2.6513796627491053,0.4939055597490413
Signaling events mediated by PRL,0.02314513005405055,9.211086474501109,1.6355403745442592
Signaling events mediated by PTP1B,3.4700949819021415e-12,27.728498542274053,11.459658637730326
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP),1.9484204065682985e-07,20.180416666666666,6.710317330540631
Signaling events mediated by VEGFR1 and VEGFR2,7.713731378644989e-15,26.388873738751023,14.112735488986111
Signaling events mediated by focal adhesion kinase,1.1024920695367053e-08,17.457070707070706,7.957624525822786
Signaling events mediated by hepatocyte growth factor receptor (c-Met),2.0460107696523444e-11,18.755656108597286,10.689092084608085
Signaling events mediated by stem cell factor receptor (c-Kit),3.4700949819021415e-12,27.728498542274053,11.459658637730326
Signaling events regulated by Ret tyrosine kinase,1.549084341136038e-10,30.442815249266864,9.80992493608662
Signaling of hepatocyte growth factor receptor,8.605527123835729e-14,41.62080903790088,13.065222522203168
Signaling pathway from G-protein families,1.7574837739569164e-08,30.288125,7.755108675931754
Signaling to ERKs,0.00046940255829402966,12.39587998208688,3.328454547779709
Signaling to p38 via RIT and RIN,0.00048084627712253786,23.50678733031674,3.3179937420622956
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway,0.0011012815371126941,16.973039215686274,2.9581016416237946
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK),4.158418702504845e-07,25.832089552238806,6.3810717845974905
Small cell lung cancer,1.9553980927694704e-06,10.815636624681852,5.708764812747458
Smooth muscle contraction,0.021353025904134706,9.650174216027875,1.6705405730814789
Sonic Hedgehog (Shh) pathway,0.011930429429686152,13.514146341463414,1.923343923841263
Sphingolipid de novo biosynthesis,0.041801612002438454,6.534067663257278,1.378806970132502
Sphingolipid metabolism,0.1619658412762598,2.8474063895568533,0.7905765688491597
Splicing regulation through Sam68,0.005015798046164786,22.530081300813006,2.299659958062889
Sprouty regulation of FGF signaling,0.011930429429686152,13.514146341463414,1.923343923841263
Sprouty regulation of tyrosine kinase signals,4.812128697038561e-05,24.081135902636916,4.317662766272701
Stabilization of mRNA by HuR,0.08531129607996224,12.612257281553399,1.0689934600354087
Stathmin and breast cancer resistance to antimicrotubule agents,0.03951921802867018,6.752195121951219,1.4031916574344458
Stress fiber formation mediated by Rho-selective guanine exchange factor AKAP13,0.11210683500664335,9.171226831421007,0.9503679082330622
Support of platelet aggregation by Eph kinases and ephrins,0.0033259674582143514,28.970034843205575,2.4780820043008283
Synaptic proteins at the synaptic junction,0.013335414315298676,12.66890243902439,1.8749934867567992
Syndecan 1 pathway,9.71384569146655e-05,12.229490806223478,4.012608799759098
Syndecan 2 pathway,1.9550671911551755e-05,17.722772277227723,4.708838312310834
Syndecan 3 pathway,0.0006905503447859054,20.370588235294118,3.1608046535579435
Syndecan 4 pathway,1.6809609616251272e-05,18.35661244695898,4.7744423724306415
Systemic lupus erythematosus,0.751292979312964,0.7213103303764755,0.12419066953889969
T cell activation co-stimulatory signal,0.19590881158612478,4.801664355062414,0.707946029869643
T cell receptor calcium pathway,1.3720455076239476e-08,31.606521739130436,7.862631483831743
T cell receptor downstream signaling,2.582102333375275e-06,28.56848184818482,5.588026549854451
T cell receptor regulation of apoptosis,1.529217619044581e-09,4.795593008028241,8.815530706853796
T cell receptor signaling in naive CD4+ T cells,1.2314567104980112e-09,18.14720812182741,8.909580850347233
T cell receptor signaling in naive CD8+ T cells,7.36936133333271e-08,17.37437185929648,7.132570148698365
T cell receptor signaling pathway,8.705883526678621e-18,18.425133689839573,17.060187147431222
T cell receptor/JNK pathway,1.149634867700561e-05,37.22704881325571,4.939440072796316
T cell receptor/Ras pathway,0.0003935395273013253,25.46691176470588,3.405011640365359
T cell signal transduction,6.479535047564786e-10,15.92954990215264,9.188456156709902
T helper cell surface molecules,0.008139138839488623,16.89512195121951,2.0894215431504537
TACI and BCMA stimulation of B cell immune responses,0.12953506652101412,7.759522031366692,0.8876126475283884
TAK1 activates NF-kappaB by phosphorylation and activation of IKK complex,0.001850052652504638,13.884358288770052,2.7328159113987014
TAK1-mediated activation of p38 MAPK,0.013335414315298676,12.66890243902439,1.8749934867567992
TAp63 pathway,0.10545682118020062,3.746883468834688,0.9769253238892951
TGF-beta receptor activation of SMADs,0.032973823514043946,7.503523035230352,1.4818306908679861
TGF-beta regulation of extracellular matrix,2.0765253246480125e-09,4.900127034057226,8.682662768003262
TGF-beta regulation of skeletal system development,0.010384834298748707,4.976811245944972,1.98360042871128
TGF-beta signaling in development,0.2348089833246225,3.877333831217326,0.6292852918635983
TGF-beta signaling in gastrointestinal stem cells,0.11210683500664335,9.171226831421007,0.9503679082330622
TGF-beta signaling pathway,2.485620076187674e-15,13.289736486051158,14.604565251971334
"TNF-alpha effects on cytokine activity, cell motility, and apoptosis",8.39058183952595e-06,7.3965640658554035,5.07620792225426
TNF-alpha signaling pathway,6.835773907790399e-05,7.62557894736842,4.165212309939427
TNF/stress-related signaling,0.030896686934087904,7.792495309568481,1.5100880876750074
TNFR1 signaling pathway,0.03728631824585162,6.985365853658537,1.4284504979594466
TNFR2 signaling pathway,0.014808510799766276,11.923098995695838,1.8294886135897137
TOR signaling,0.2931904246163953,2.9638777841233583,0.5328502175376227
TP53 network,0.1798032676389488,5.30761369443025,0.7452024199183122
TPO signaling pathway,0.00011565024196951087,18.603672189879088,3.9368534542386846
TRAF6 mediated NF-kB activation,0.20384316548076056,4.5831862312444835,0.6907038451328491
TRAF6-mediated IRF7 activation in TLR7/8 or 9 signaling,2.8667980105800312e-06,58.51090781140042,5.54260290558188
TRAF6-mediated induction of TAK1 complex,0.14662282396907042,6.724271844660194,0.8337984201977292
TRAIL signaling pathway,0.032973823514043946,7.503523035230352,1.4818306908679861
TSH regulation of gene expression,5.444812821048194e-07,10.574055158324821,6.264017045602085
TSP1-induced apoptosis in microvascular endothelial cell,7.589958636213026e-05,50.9485294117647,4.119760590917877
TWEAK regulation of gene expression,0.24236129059834613,3.733549083063646,0.615536743507379
TWEAK signaling pathway,6.2936485494357e-05,13.519411151641478,4.201097512662445
Taste transduction,0.09615017541374164,3.9678622668579626,1.017049919109843
Telomerase protein component gene hTERT transcriptional regulation,0.11210683500664335,9.171226831421007,0.9503679082330622
Telomerase regulation,1.2314567104980112e-09,18.14720812182741,8.909580850347233
"Telomeres, telomerase, cellular aging, and immortality",0.0009508300728066499,17.972318339100347,3.021897090882179
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis,0.00013471996055583154,17.793960162775754,3.870568052999913
Th1/Th2 differentiation pathway,0.21169960180366107,4.383706205149852,0.6742799588659699
Thrombin signaling through protease-activated receptors,0.016196654053573338,5.980968858131488,1.7905746938619844
Thromboxane A2 receptor signaling,4.410164238678812e-09,19.644886363636363,8.355545236694578
Thymic stromal lymphopoietin (TSLP) pathway,0.22613891489215357,2.2695533022745957,0.6456246960859192
Thyroid cancer,1.3720455076239476e-08,31.606521739130436,7.862631483831743
Thyroid-stimulating hormone signaling pathway,5.161470055677096e-05,10.145338879373623,4.287226587880092
Tie2 signaling,3.164979791586005e-05,27.29458128078818,4.499629058610513
Tight junction,0.14641404658249912,2.3194881005837447,0.8344172561967963
Tob role in T-cell activation,0.01634825310276179,11.260162601626016,1.7865286471849426
Toll receptor cascades,2.933905709102326e-14,13.8504359490275,13.53255384777787
Toll-like receptor endosomal trafficking and processing,0.12086392882947664,8.406553398058252,0.9177032925860766
Toll-like receptor signaling pathway regulation,6.202885160427806e-14,14.67581453634085,13.207406259243577
Transcription,0.8364692376612087,0.5528080244595827,0.07755002620146634
Transcription factor regulation of microRNAs related to cardiac hypertrophy,0.08531129607996224,12.612257281553399,1.0689934600354087
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer,5.6064511985680974e-05,13.885469628043886,4.25131195381741
Transcriptional regulation of white adipocyte differentiation,0.17948564208304071,2.659435173299101,0.7459702869937775
Transferrin endocytosis and recycling,0.25724407997113713,3.4757281553398056,0.5896546109890537
Transmembrane transport of small molecules,0.8030446323328833,0.6964090287277702,0.09526031644334045
Transmission across chemical synapses,0.011820326320143454,3.3252117789431224,1.9273705338539664
Transport of inorganic cations/anions and amino acids/oligopeptides,0.6144748133281146,1.057639243740419,0.21149591368361606
Trefoil factor initiation of mucosal healing,3.8867155274159584e-05,15.112842166569598,4.41041724465162
Tumor necrosis factor (TNF) pathway,0.003462145004239394,10.905987394957982,2.460654746621737
Tumor suppressor Arf inhibits ribosomal biogenesis,0.024996875915054558,8.8101802757158,1.6021142656332958
Type 1 diabetes mellitus,0.35358600024970316,2.3425152404606004,0.4515049386099409
Type 2 diabetes mellitus,6.548517070274427e-07,16.504886363636363,6.183857036055903
Type I interferon (interferon-alpha/beta) pathway,0.01463858120546012,6.225690276110444,1.8345010137488682
Type II interferon signaling (interferon-gamma),0.013892987691929051,6.3556985294117645,1.857204349036294
Ubiquitin-mediated degradation of phosphorylated Cdc25A,0.4752750601065672,1.5722845873786409,0.32305497455917664
Ubiquitin-mediated proteolysis,0.011616062079476337,3.8743249324932494,1.9349410756469112
"Unblocking of NMDA receptor, glutamate binding and activation",0.013335414315298676,12.66890243902439,1.8749934867567992
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,6.2936485494357e-05,13.519411151641478,4.201097512662445
VEGF signaling pathway,1.0954896248918057e-05,10.361500000000001,4.960391731178196
"VEGF, hypoxia, and angiogenesis",6.2936485494357e-05,13.519411151641478,4.201097512662445
VEGFR1 pathway,8.114394533501107e-09,34.62,8.090743880097689
Validated nuclear estrogen receptor alpha network,0.026374402164942447,4.917220113851992,1.5788173758424664
Vascular smooth muscle contraction,2.4321337372342756e-06,8.705808080808081,5.614012547924811
Vasopressin-regulated water reabsorption,0.07263836187760435,4.707884288145207,1.1388339584784226
Vibrio cholerae infection,0.10545682118020062,3.746883468834688,0.9769253238892951
Viral myocarditis,0.0007261094945246084,7.657011969853701,3.138997884420759
Visceral fat deposits and the metabolic syndrome,0.08531129607996224,12.612257281553399,1.0689934600354087
Visual signal transduction: cones,0.21169960180366107,4.383706205149852,0.6742799588659699
Visual signal transduction: rods,0.21169960180366107,4.383706205149852,0.6742799588659699
Vitamin B12 metabolism,0.0154064471362638,6.100882352941176,1.8122975019055534
Vitamin D biosynthesis,0.08531129607996224,12.612257281553399,1.0689934600354087
Wnt interactions in lipid metabolism and immune response,3.1563693818348994e-07,18.625384615384615,6.500812178116152
Wnt signaling pathway,1.7879137360453754e-12,9.764758765358104,11.74765343904304
Wnt signaling pathway and pluripotency,3.8660177594709165e-09,13.204719387755102,8.412736155268018
Wnt/LRP6 signaling,0.07620181512199029,14.414701803051319,1.1180346836725295
Wnt/calcium/cyclic GMP pathway,0.006460924624604004,5.750919308957192,2.189705325560899
Y branching of actin filaments,0.19590881158612478,4.801664355062414,0.707946029869643
cAMP cell motility pathway inferred from amoeba model,0.004565704281532014,6.382081280788177,2.340492220979356
"cAMP receptor, G-protein-independent pathways inferred from amoeba model",0.09433137905416296,11.210355987055015,1.0253438164545743
eIF2 regulation,0.11210683500664335,9.171226831421007,0.9503679082330622
eIF4E and p70 S6 kinase regulation,7.245261108651564e-06,22.35256134309083,5.13994595857056
eIF4E release,0.06700205450091128,16.817961165048544,1.1739118802136672
fMLP induced chemokine gene expression in HMC-1 cells,2.6067398810115872e-05,16.577770680293835,4.583902303652348
mRNA stability regulation by proteins that bind AU-rich elements,0.2116579729220212,2.3768149210903875,0.6743653674884753
mTOR signaling pathway,1.3998428605273178e-09,12.483257918552036,8.85392071334758
p38 MK2 pathway,0.001265953007054112,16.07894736842105,2.897582415294869
p38 alpha/beta MAPK downstream pathway,0.05647041131626566,5.4729070533948585,1.2481790489598814
p38 gamma/delta MAPK pathway,0.11210683500664335,9.171226831421007,0.9503679082330622
p38-alpha and p38-beta regulation,0.003462145004239394,10.905987394957982,2.460654746621737
p53 activity regulation,0.006539259989494245,4.489968733715476,2.1844713955079986
p53 signaling pathway,1.4628327504506417e-07,8.990033222591363,6.8348053250766965
p73 transcription factor network,0.044617674941945275,3.9564553093964854,1.3504930648498605
p75 neurotrophin receptor signaling via NF-kB,1.9737048177360248e-05,31.49677908298598,4.704717798786067
p75 neurotrophin receptor-mediated signaling,4.6158141682794896e-07,9.127344956963142,6.335751684106085
